Guidance for Implementing a Remote Assessment Strategy as a Protocol Adaptation During the COVID-19 Pandemic Date Published: May 08, 2020 Whitepaper This white paper offers guidance on implementing remote assessment for studies operating during the COVID-19 crisis. Signant Health experts, Dan Debonis and Gary Sachs, discuss methods to collect data that will identify where and how remote ratings are used. They also offer principles to maximize the quantity and quality of data even while operating under conditions of uncertainty. Learn about the important considerations regarding: Legal & regulatory needsOperationsClinical requirementsLogisticsSafetyEngagement Download Now Share: LinkedInTweet Recommended Resources The EMA Recommendation Paper on Decentralized Elements in Clinical Trials: An Overview Read Our White Paper Whitepaper Optimal COA Measurement Strategy in Modern Oncology Trials Read Our White Paper Whitepaper Site Perspectives on BYOD ePRO Use Download Whitepaper